PharVision Advisers’s Molson Coors Class B TAP Stock Holding History

PharVision Advisers’s Portfolio TAP Stock Details TAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,699	Closed	-$453K	–	585
2025 Q4	$453K	Buy	+9,699	New	+$447K	0.23%	70

Other funds holding TAP

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's TAP Position: Q1 2026 in Review

PharVision Advisers sold out of Molson Coors Class B (TAP) in Q1 2026, closing a stake of 9,699 shares — an estimated $453K sold.

PharVision Advisers first reported a position in TAP in Q4 2025 and held it in 1 quarter. The position peaked at $453K in Q4 2025. 625 funds tracked by Wall St. Rank hold TAP as of Q1 2026.

PharVision Advisers reported no remaining Molson Coors Class B position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 9,699 Molson Coors Class B shares in Q1 2026, an estimated $453K.
PharVision Advisers first reported a position in Molson Coors Class B in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Molson Coors Class B position peaked at $453K in Q4 2025.
625 funds tracked by Wall St. Rank held Molson Coors Class B as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.